# Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

> **NCT01673269** · NA · COMPLETED · sponsor: **Texas Tech University Health Sciences Center, El Paso** · enrollment: 60 (actual)

## Conditions studied

- Choledocholithiasis
- Cholangiocarcinoma
- Benign Stricture of Common Bile Duct

## Interventions

- **OTHER:** Blood culture ( aerobic and anaerobic)

## Key facts

- **NCT ID:** NCT01673269
- **Lead sponsor:** Texas Tech University Health Sciences Center, El Paso
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673269, "Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01673269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*